NCT07002697

Brief Summary

The study investigates the use of advanced imaging techniques and computational methods to identify high-risk plaques in coronary arteries. These plaques are significant because they have the potential to cause acute coronary syndrome (ACS), a condition that includes heart attacks and unstable angina. The research focuses on integrating Coronary Computed Tomography (CCT) with Computational Fluid Dynamics (CFD) to provide detailed insights into plaque characteristics and their hemodynamic environment. The study's primary aim is to enhance the early detection and characterization of high-risk coronary plaques that could lead to ACS. By combining CCT, a non-invasive imaging technique, with CFD, which stimulates blood flow dynamics, the study seeks to: Identify High-Risk Plaques, Apply CFD to analyze the blood flow around these plaques, Improve Prediction of ACS, Inform Clinical Decision-Making. Computational fluid dynamics (CFD) analysis of CCT data can also provide a non-invasive hemodynamic assessment to identify high-risk plaques destined to cause acute coronary syndrome. Patients with adverse plaque characteristics like positive remodeling or low-attenuation plaque have a greater risk of future coronary events.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 10, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 3, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2026

Completed
Last Updated

June 3, 2025

Status Verified

May 1, 2025

Enrollment Period

1.2 years

First QC Date

April 19, 2025

Last Update Submit

May 25, 2025

Conditions

Keywords

Computational Fluid Dynamics (CFD)Design Of Experiment (DOE)Computed Tomography (CT)Acute Coronary Syndrome (ACS)

Outcome Measures

Primary Outcomes (1)

  • Geometrical Influences on Atherosclerosis and Blood Flow: A Computational Fluid Dynamics and Experimental Design Approach

    The primary outcome of this study is the focus on evaluating the impact of vascular geometry on blood flow patterns and their role in the development of atherosclerosis. Using Computational Fluid Dynamics (CFD) simulations, the study investigates critical hemodynamic factors, such as wall shear stress, pressure gradients, and recirculation zones, which are influenced by variations in vessel geometry. By integrating experimental data with computational models, the study aims to identify specific geometrical features that contribute to plaque formation and progression, ultimately enhancing the understanding of atherosclerosis and guiding targeted interventions.

    Each patient is monitored for upto 1 year after enrollment to assess plaque changes and hemodynamics via periodic imaging and analysis.

Study Arms (1)

People who have Acute Coronary Syndrome and did a CT angiogram

In observational studies aimed at identifying high-risk plaques using coronary computed tomography (CT) and computational fluid dynamics (CFD), the group or cohort typically consists of people having diagnostic imaging for suspected or established coronary artery disease (CAD). Participants are frequently chosen based on clinical indicators such as chest discomfort, a history of myocardial infarction, or abnormal stress test findings. Cohort characteristics include age, gender, cardiovascular risk factors (such as hypertension, diabetes, hyperlipidaemia, and smoking), and previous CAD therapies. The study will examine plaque features (e.g., low-attenuation plaques, positive remodelling) and hemodynamic parameters generated from CFD (e.g., wall shear stress, pressure gradients) to stratify risk. Detailed demographic, clinical, and imaging data are collected to examine relationships between plaque features and cardiovascular outcomes, ensuring a thorough analysis.

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population includes patients diagnosed with atherosclerosis, identified through CT angiography (CTA). High-resolution CT scan data reconstruct patient-specific vascular geometries, focusing on regions of clinical interest, such as arterial bifurcations and stenotic segments. Key parameters include Curvature, Surface Roughness, stenosis severity and bifurcation angles, allowing for a detailed computational fluid dynamics (CFD) analysis of hemodynamic forces contributing to endothelial dysfunction and plaque progression.

You may qualify if:

  • Adults aged 40-70 years.
  • Presenting with symptoms of CAD (e.g., chest pain, shortness of breath) or having multiple risk factors (e.g., hypertension, diabetes, smoking).
  • Able to provide informed consent.

You may not qualify if:

  • Severe renal impairment (due to contrast media risk).
  • Previous allergic reaction to iodinated contrast media.
  • Pregnant or lactating women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Cardiovascular Disease (NICVD)

Dhaka, 1207, Bangladesh

RECRUITING

MeSH Terms

Conditions

AtherosclerosisAcute Coronary Syndrome

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesMyocardial IschemiaHeart Diseases

Study Officials

  • Muhammad Tarik Arafat, PhD

    Department of Biomedical Engineering, Bangladesh University of Engineering and Technology (BUET), Dhaka - 1205

    PRINCIPAL INVESTIGATOR
  • Dr. M G Azam, MBBS, MD, FSCAI

    NICVD, Dhaka

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Muhammad Tarik Arafat, PhD

CONTACT

Md. Siam Ahmed Nishat, B.Sc. in ENgineering

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 19, 2025

First Posted

June 3, 2025

Study Start

August 10, 2024

Primary Completion

October 11, 2025

Study Completion

April 11, 2026

Last Updated

June 3, 2025

Record last verified: 2025-05

Locations